<DOC>
	<DOCNO>NCT01373970</DOCNO>
	<brief_summary>Proton pump inhibitor ( PPI ) show cause acid reflux relate symptom withdrawal healthy volunteer , phenomenon know Rebound Acid Hyper Secretion . Whether also apply patient dyspeptic symptom without true reflux disease ( functional dyspepsia ) treat PPI unknown . If case , could lead unfortunate long term use PPI , since acid rebound render withdrawal difficult . This single centre , randomize , double-blinded , placebo-controlled cross study . Study period 12 week per study subject . Study subject refer study General Practitioner ( GP ) gastroenterology department endoscopy clinic investigational centre . The study population consist patient seek GP dyspepsia without alert sign , GP may consider start PPI . Out patient referred gastroenterology department endoscopy clinic investigational centre dyspepsia without specific exclusion criterion also invite participate . Baseline interview , upper endoscopy pH monitoring perform one week inclusion exclude patient GERD . Helicobacter Pylori ( Hp . ) status assess Helicobacter Urease Test ( HUT ) . Hp . positive subject without ulcus exclude . Patients positive pH monitoring include analysis regard primary endpoint ( Development GERD ) include analysis regard one secondary endpoint ( Effect PPI Functional Dyspepsia ) . Study subject randomize either pantoprazol follow cross placebo placebo . Escape medication form Gaviscon use demand . Internet base questionnaire answer weekly . Questionnaires consist Gastrointestinal Symptom rating Scale ( GSRS ) combination item assess postprandial fullness item assess Montreal Criteria Gastro Esophageal Reflux Disease ( GERD ) . Compliance protocol assess hospital visit every fourth week . At end study endoscopy pH monitoring repeat .</brief_summary>
	<brief_title>The Clinical Significance Acid Rebound Functional Dyspepsia</brief_title>
	<detailed_description />
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Gastritis</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Symptoms indicate dyspepsia , include : Epigastric pain epigastric discomfort Bothersome postprandial fullness Early satiation Epigastric burn Access internet Daily use PPI H2receptor antagonists 28 day within last 120 day OR two day within last 28 day OR five nonconsecutive day within last 28 day . Mild heartburn regurgitation per week Moderate severe heartburn regurgitation least per week Complications GERD ( esophagitis , stricture Barrett 's esophagus ) prior enrolment screen Abnormal finding upper endoscopy necessitate treatment Abnormal pHmonitoring prior enrolment screening ( pH &lt; 4 â‰¥5.5 % time `` bad day '' 48h monitoring ) Excludes data analysis regard primary endpoint ( see summary ) Previous surgery esophagus , stomach duodenum Regular use NSAIDs last six month Potential language problem understand information register symptom Pregnancy breast feed Other disease interfere symptom registration ( severe congestive heart disease , malignant disease , schizophrenia ect . ) Abuse alcohol/narcotics Allergy/intolerance gelatine lactose use placebo Patients pacemaker , Implantable Cardioverter Defibrillator Implantable Neurostimulator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Functional Dyspepsia</keyword>
	<keyword>Protonpump inhibitor</keyword>
	<keyword>Rebound Acid HyperSecretion</keyword>
</DOC>